Alliance Pharma PLC
LSE:APH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Lupin Ltd
NSE:LUPIN
|
IN |
Alliance Pharma PLC
Total Equity
Alliance Pharma PLC
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Alliance Pharma PLC
LSE:APH
|
Total Equity
£207.6m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
11%
|
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Total Equity
£16.4B
|
CAGR 3-Years
16%
|
CAGR 5-Years
2%
|
CAGR 10-Years
12%
|
|
|
AstraZeneca PLC
LSE:AZN
|
Total Equity
$48.7B
|
CAGR 3-Years
10%
|
CAGR 5-Years
26%
|
CAGR 10-Years
10%
|
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Total Equity
$2.6B
|
CAGR 3-Years
7%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
|
Allergy Therapeutics PLC
LSE:AGY
|
Total Equity
-£28.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Animalcare Group PLC
LSE:ANCR
|
Total Equity
£113.2m
|
CAGR 3-Years
12%
|
CAGR 5-Years
6%
|
CAGR 10-Years
18%
|
|
Alliance Pharma PLC
Glance View
Alliance Pharma Plc is a holding company, which engages in the acquisition, marketing, and distribution of healthcare and pharmaceutical products. The company is headquartered in Chippenham, Wiltshire and currently employs 255 full-time employees. The company went IPO on 2001-11-22. The firm is primarily engaged in the acquisition, marketing and distribution of healthcare and pharmaceutical products. The company is focused on two areas, which include Consumer Healthcare brands and Prescription Medicines. The Company’s Consumer Healthcare brands include Kelo-Cote, Nizoral, Amberen, MacuShield, Vamousse and Aloclair. Its Prescription Medicines include Hydromol, Flamma Franchise and Forceval. Its brands also include Ashton & Parsons and Anbesol. The Company’s products include Alliance Calcium Syrup, Amantadine hydrochloride, Aiweidi, Biodermatin, Biotaches, Buccastem M, Changmin, Decapional, Dermachronic, Dermacide, Dervida, Effadiane, Fazol, Gen-Ongles, Irenat, ISIB, Isocarboxazid, Jonctum, Kelo-Stretch, Lypsyl, Lefuzhi, Malunjunshe, MolluDab, Menadiol, Neostigmine and Nu-Seals. Its geographical area includes Europe, Middle East and Africa (EMEA), Asia Pacific and China (APAC) and Americas (AMER).
See Also
What is Alliance Pharma PLC's Total Equity?
Total Equity
207.6m
GBP
Based on the financial report for Dec 31, 2024, Alliance Pharma PLC's Total Equity amounts to 207.6m GBP.
What is Alliance Pharma PLC's Total Equity growth rate?
Total Equity CAGR 10Y
11%
Over the last year, the Total Equity growth was -5%. The average annual Total Equity growth rates for Alliance Pharma PLC have been -10% over the past three years , -5% over the past five years , and 11% over the past ten years .
